Until October 6, 2022, the so-called Public Consultation ran, in which stakeholders could respond to the arguments of ECHA (European Chemicals Agency). The Risk Assessment Committee (RAC), under pressure from the European Ombudsman, had to allow a new phase of comments. And the headwind was enormous.